Harbor Capital Advisors, Inc. Dynavax Technologies Corp Transaction History
Harbor Capital Advisors, Inc.
- $1.29 Billion
- Q3 2025
A detailed history of Harbor Capital Advisors, Inc. transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Harbor Capital Advisors, Inc. holds 294 shares of DVAX stock, worth $2,881. This represents 0.0% of its overall portfolio holdings.
Number of Shares
294
Previous 590
50.17%
Holding current value
$2,881
Previous $6,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding DVAX
# of Institutions
294Shares Held
121MCall Options Held
294KPut Options Held
77.6K-
Black Rock Inc. New York, NY21.9MShares$215 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT17.8MShares$174 Million6.26% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.43MShares$82.6 Million0.0% of portfolio
-
State Street Corp Boston, MA6.4MShares$62.7 Million0.0% of portfolio
-
Chicago Capital, LLC5.23MShares$51.2 Million1.29% of portfolio
About DYNAVAX TECHNOLOGIES CORP
- Ticker DVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 126,474,000
- Market Cap $1.24B
- Description
- Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...